| Tag | Content |
|---|
EnhancerAtlas ID | HS105-33133 |
Organism | Homo sapiens |
Tissue/cell | IMR90 |
Coordinate | chr17:15351580-15352350 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| EWSR1-FLI1 | MA0149.1 | chr17:15352021-15352039 | TTTTCCTTCCTTCCTCCT | - | 6.33 | | PRDM1 | MA0508.2 | chr17:15351684-15351694 | GTGAAAGTGA | - | 6.02 | | Stat4 | MA0518.1 | chr17:15351645-15351659 | CTTCCAGGAAGGGA | + | 6.06 | | ZNF263 | MA0528.1 | chr17:15352020-15352041 | ATTTTCCTTCCTTCCTCCTCC | - | 6.42 | | ZNF263 | MA0528.1 | chr17:15352023-15352044 | TTCCTTCCTTCCTCCTCCTCT | - | 6.87 |
|
| | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_30004 | chr17:15351313-15352355 | Fetal_Muscle |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH17I015447 | chr17 | 15350976 | 15352366 |
|
Enhancer Sequence | GGAACTGCAC ATCCTCCAAA TATCCCAGCC CATAGCATGA CCATGCAGAA AACACTTTCC 60
TAACCCTTCC AGGAAGGGAA TCACTCATGT GCTCTCAGAG GAAGGTGAAA GTGACTGTAT 120
TATAAATAGT GTGTGTCACA ATTACATTGA GAAATTGCCA GAAAGCAAAA GGTGTAGGGC 180
TTTACTTCAG GCCTCACGTA AACTGATGAC CTTGCATTCA AAATCTGAAA AGCTGAGGGT 240
AAGAAGCTGA AATGTGGAGA CACACACCCT CTCTCCCTTC TGCCGCAGAC ACCCCTGGGA 300
CTTTCTGCCA AGAGAACTTT GTCAGGTCAT CATCAGGAGA CGCGCTCTCT CTCCTGGGCC 360
TTTGCAGGCC TCTCAAGGAA AGGTTGTTCC GGAGCCTGGA GGCAGTCACT TTCCTTCCCC 420
ACTACTGCCA TCCTCAAACC ATTTTCCTTC CTTCCTCCTC CTCTGAAGCT TGTGCCCCCA 480
GGCTACACCA CCACCTCACC TGCCCGGTTG CTGCCAGCTC CTGAGCGCTG TCCTCTGCCC 540
CTCAGTCCCT GACAACTTGA GCCCCAGGCA CACTGTCCTC CTTTGCGCTG TTCCCTGTCA 600
TCACCGTGGC TTCTTCATTG TCTCCTGAAT GATCTGTGCA GACCTCCAGC CCAGCAGTCC 660
TTGACCTGCT CATTTCCAAT CACCAGGTCT TCCTCTCAGT CTCCACCACC CGTGCCTCTG 720
TGATCAGGCC ACTGTTCTTA TCATCCCCAA TAACGATGCT ACATCCAAAA 770
|
